Form 4 for SPRY ARS Pharmaceuticals, Inc.
Accepted 2024-12-04 00:00:00 ET · period of report 2024-12-02 · accession 0001415889-24-028350 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-04 | 2024-12-02+ | SPRY | Shawver Laura | Dir | M - OptEx | $2.00 | +200.0K | 298.3K | +203% | +$399.0K |
| DM | 2024-12-04 | 2024-12-02+ | SPRY | Shawver Laura | Dir | S - Sale+OE | $13.44 | -200.0K | 210.3K | -49% | -$2.69M |
| DM | 2024-12-04 | 2024-12-02+ | SPRY | Shawver Laura | Dir | M - OptEx | $0.00 | -200.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-03 | M | A | 25,606 | $1.27 | 235,952 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-02 | M | A | 67,616 | $1.27 | 277,962 | D | — | — | |
| 3 | Common | Common Stock | 2024-12-04 | S | D | 14,772 | $13.75 | 210,346 | D | — | — | (F5) The weighted average sale price for the transaction reported was $13.7496 and the range of prices were between $13.39 and $14.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 4 | Common | Common Stock | 2024-12-04 | M | A | 14,772 | $3.15 | 225,118 | D | — | — | |
| 5 | Common | Common Stock | 2024-12-02 | S | D | 96,343 | $13.55 | 211,247 | D | — | — | (F2) The weighted average sale price for the transaction reported was $13.5539 and the range of prices were between $13.27 and $14.20. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 6 | Common | Common Stock | 2024-12-02 | S | D | 901 | $14.34 | 210,346 | D | — | — | (F3) The weighted average sale price for the transaction reported was $14.3417 and the range of prices were between $14.2761 and $14.375. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 7 | Common | Common Stock | 2024-12-02 | M | A | 29,628 | $1.27 | 307,590 | D | — | — | |
| 8 | Common | Common Stock | 2024-12-03 | M | A | 62,378 | $3.15 | 298,330 | D | — | — | |
| 9 | Common | Common Stock | 2024-12-03 | S | D | 87,984 | $13.26 | 210,346 | D | — | — | (F4) The weighted average sale price for the transaction reported was $13.2626 and the range of prices were between $12.92 and $13.62. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 10 | Derivative | Stock Option (Right to Buy) | 2024-12-04 | M | D | 14,772 | $0.00 | 59,064 | D | $3.15 · — to 2032-05-01 | 14,772 Common Stock | (F6) Immediately exercisable. |
| 11 | Derivative | Stock Option (Right to Buy) | 2024-12-03 | M | D | 62,378 | $0.00 | 73,836 | D | $3.15 · — to 2032-05-01 | 62,378 Common Stock | (F6) Immediately exercisable. |
| 12 | Derivative | Stock Option (Right to Buy) | 2024-12-02 | M | D | 67,616 | $0.00 | 0 | D | $1.27 · — to 2030-04-28 | 67,616 Common Stock | (F7) Due to a clerical error, the total number of shares subject to this option grant was underreported by one share on the Reporting Person's Form 3 and is corrected on this filing. (F6) Immediately exercisable. |
| 13 | Derivative | Stock Option (Right to Buy) | 2024-12-02 | M | D | 29,628 | $0.00 | 25,606 | D | $1.27 · — to 2030-04-28 | 29,628 Common Stock | (F6) Immediately exercisable. |
| 14 | Derivative | Stock Option (Right to Buy) | 2024-12-03 | M | D | 25,606 | $0.00 | 0 | D | $1.27 · — to 2030-04-28 | 25,606 Common Stock | (F6) Immediately exercisable. |